Approval · Notice of Compliance 4119 · 1997
MODULON: Notice of Compliance 4119
Issued October 24, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4119
- Date
- October 24, 1997
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Lower gastrointestinal tract motility regulator
Products in this notice
Medicinal ingredients
- TRIMEBUTINE MALEATE 100 MG per TAB
- TRIMEBUTINE MALEATE 200 MG per TAB
- TRIMEBUTINE MALEATE 10 MG per ML